Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular Carcinoma
Clinical trial NCT01348503 · TERMINATED
Trial details
- NCT number
- NCT01348503
- Sponsor
- Indiana University
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2012-12-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.